Skip to content
PB
Company

Updated:

Provention Bio, Inc.

Provention Bio, Inc. is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0001695357, and its reported industry is...

Overview

Provention Bio, Inc. is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0001695357, and its reported industry is Pharmaceutical Preparations. In 10-K filed on 2023-03-29, it reported annual revenue of USD 12,895,000; net income of USD -113,565,000; total assets of USD 236,856,000 for the fiscal period ended 2022-12-31. The financial history preserves reporting periods, currencies, filing accessions and source provenance. Figures are reported filing data, rather than real-time estimates.

Company overview

Legal name
Provention Bio, Inc.
Classification
Company
Industry (SIC)
2834 — Pharmaceutical Preparations
Headquarters
Red Bank, NJ, United States
Incorporated in
DE
Fiscal year end
December 31
SEC CIK
0001695357

Financials

Annual figures as originally reported. Currency is shown for each fiscal year; B means billion and M means million.

Fiscal yearPeriod endRevenueNet incomeTotal assetsCash and equivalentsOperating cash flow
FY2022USD$12.9M-$113.6M$236.9M$44.0M-$75.4M
FY2021USD$1.4M-$114.4M$135.6M$78.2M-$95.4M
FY2020USD—-$98.6M$128.5M$102.3M-$76.3M
FY2019USD—-$43.3M$86.0M$39.2M-$36.1M

Recent SEC filings

FormFiledPeriodFiling
8-KForm 8-K
10-KForm 10-K
8-KForm 8-K
SC 13G—PROVENTION BIO, INC.
8-KForm 8-K
8-KForm 8-K
8-KForm 8-K
8-KForm 8-K
8-KForm 8-K
10-QForm 10-Q
8-KForm 8-K
8-KForm 8-K

Profile maintained by Altss. Updated: . To correct this record or make a privacy request, send the page URL and your evidence to privacy@altss.com; corrections are free.

Research Provention Bio, Inc. in Altss

Track this company’s investors, transactions and relationships in Altss.

Book a demo

More Company profiles

Provention Bio, Inc. | Red Bank Company | Altss